Skip to Content

KRC KRC (Cefaclor 250 mg)

Pill imprint KRC KRC has been identified as Cefaclor 250 mg.

Cefaclor is used in the treatment of urinary tract infection; kidney infections; bronchitis; pneumonia; otitis media (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Cefaclor 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Cefaclor 250 mg KRC KRC
Discount Card Promo
Cefaclor
Imprint:
KRC KRC
Strength:
250 mg
Color:
Blue & Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Second generation cephalosporins
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Alvogen, Inc.
National Drug Code (NDC):
47781-0266
Inactive Ingredients:
magnesium stearate
lactose monohydrate
magnesium silicate
sodium glycolate
gelatin
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 3
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
61442-0171 Carlsbad Technology, Inc.
60429-0701 Golden State Medical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide